Actively Recruiting
Advanced Multi-omics Approaches to Discover New Biomarkers in Spinal Muscular Atrophy with Genetic Confirmation
Led by Istituto Giannina Gaslini · Updated on 2026-10-20
200
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Spinal muscular atrophy SMA is a genetic neuromuscular disorder caused by mutations in the SMN1 gene, leading to loss of motor neurons and progressive muscle wasting. The disease varies widely in progression and response to available treatments, making clinical management difficult. Researchers are conducting this observational study to identify and validate new biomarkers to better diagnose, predict outcomes, and monitor treatment responses in SMA. The study uses advanced multi-omics and system biology techniques to analyze patients with genetically confirmed SMA, including symptomatic individuals and newborns detected through screening. Healthy, age-matched control participants without neuromuscular diseases are also included for comparison. The study involves collecting biological specimens such as blood samples and applying translational research methods to discover molecular markers linked to disease types and treatment effects. Participants will undergo procedures including blood sampling and specimen collection with consent from legal guardians for minors. Researchers will measure biomarkers to distinguish SMA patients from healthy controls, predict disease progression, and assess treatment response. Outcomes include functional validation of biomarkers in SMA organoids and development of prognostic algorithms over an average follow-up of two years. The study also monitors safety and compliance during participation, which lasts until study completion in late 2026.
CONDITIONS
Brief Title
Advanced Multi-omics and -System Approaches to Identify Novel Biomarkers for SMA
Research Team
C
Claudio Bruno, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here